Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Jin Medical International Ltd. (ZJYL)

1.8950 -0.0984 (-4.94%)
As of 10:06:47 AM EDT. Market Open.
Chart Range Bar
Loading chart for ZJYL
  • Previous Close 1.9934
  • Open 1.9700
  • Bid 2.8700 x 100
  • Ask 2.7800 x 100
  • Day's Range 1.8950 - 2.0350
  • 52 Week Range 1.5300 - 8.4800
  • Volume 13,327
  • Avg. Volume 722,712
  • Market Cap (intraday) 141.487M
  • Beta (5Y Monthly) 7.41
  • PE Ratio (TTM) 9.97
  • EPS (TTM) 0.1900
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.

www.zhjmedical.com

273

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZJYL
56.93%
S&P 500 (^GSPC)
12.95%

1-Year Return

ZJYL
69.53%
S&P 500 (^GSPC)
12.21%

3-Year Return

ZJYL
79.86%
S&P 500 (^GSPC)
87.79%

5-Year Return

ZJYL
76.31%
S&P 500 (^GSPC)
68.22%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.95%

  • Return on Assets (ttm)

    0.50%

  • Return on Equity (ttm)

    4.02%

  • Revenue (ttm)

    19.73M

  • Net Income Avi to Common (ttm)

    1.17M

  • Diluted EPS (ttm)

    0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.1M

  • Total Debt/Equity (mrq)

    69.34%

  • Levered Free Cash Flow (ttm)

    -7.49M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: